Standpoint Research Lifts Target on Amdocs (DOX) to $34

December 4, 2009 9:01 AM EST Send to a Friend
Standpoint Research raised their price target on Amdocs (NYSE: DOX) from $30 to $34, reiterating their Buy rating.

The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login